Insiders · Profile

Garg Pushkal

EVP Chief R&D at ALNYLAM PHARMACEUTICALS. Filing since 3 Mar 2023. CIK 0001829252

Company

Date

Role

Action

Shares

Amount

Of holding

ALNY ALNYLAM PHARMACEUTICALS, INC.

5 Mar 2026

EVP Chief R&D

Sold on a plan

2,404

$778.81K

11.4%

ALNY ALNYLAM PHARMACEUTICALS, INC.

4 Mar 2026

EVP Chief R&D

Sold on a plan

2,309

$745.98K

9.9%

ALNY ALNYLAM PHARMACEUTICALS, INC.

3 Mar 2026

EVP Chief R&D

Sold on a plan

1,775

$567.55K

7.0%

ALNY ALNYLAM PHARMACEUTICALS, INC.

2 Mar 2026

EVP Chief R&D

Sold on a plan

1,717

$562.59K

6.4%

ALNY ALNYLAM PHARMACEUTICALS, INC.

27 Feb 2026

EVP Chief R&D

Sold on a plan

4,627

$1.53M

17.3%

ALNY ALNYLAM PHARMACEUTICALS, INC.

13 Feb 2026

EVP Chief R&D

Sold at will

2,242

$695.20K

8.3%

ALNY ALNYLAM PHARMACEUTICALS, INC.

12 Jan 2026

EVP Chief R&D

Sold at will

1,510

$547.93K

6.3%

ALNY ALNYLAM PHARMACEUTICALS, INC.

3 Oct 2025

EVP Chief R&D

Sold on a plan

3,022

$1.36M

13.0%

ALNY ALNYLAM PHARMACEUTICALS, INC.

2 Oct 2025

EVP Chief R&D

Sold on a plan

2,937

$1.33M

11.2%

ALNY ALNYLAM PHARMACEUTICALS, INC.

19 Aug 2025

EVP Chief R&D

Sold on a plan

1,455

$666.99K

6.7%

ALNY ALNYLAM PHARMACEUTICALS, INC.

18 Aug 2025

EVP Chief R&D

Sold on a plan

1,396

$632.76K

6.1%

ALNY ALNYLAM PHARMACEUTICALS, INC.

24 Mar 2025

CMO & EVP Dev & Med Affairs

Sold on a plan

5,445

$1.63M

21.2%

ALNY ALNYLAM PHARMACEUTICALS, INC.

21 Mar 2025

CMO & EVP Dev & Med Affairs

Sold on a plan

4,321

$1.23M

17.6%

ALNY ALNYLAM PHARMACEUTICALS, INC.

4 Mar 2025

CMO & EVP Dev & Med Affairs

Sold on a plan

808

$194.77K

3.2%

ALNY ALNYLAM PHARMACEUTICALS, INC.

3 Mar 2025

CMO & EVP Dev & Med Affairs

Sold on a plan

1,749

$426.38K

6.5%

ALNY ALNYLAM PHARMACEUTICALS, INC.

28 Feb 2025

CMO & EVP Dev & Med Affairs

Sold at will

935

$225.98K

6.7%

ALNY ALNYLAM PHARMACEUTICALS, INC.

18 Feb 2025

CMO & EVP Dev & Med Affairs

Sold on a plan

1,548

$389.58K

11.4%

ALNY ALNYLAM PHARMACEUTICALS, INC.

14 Feb 2025

CMO & EVP Dev & Med Affairs

Sold on a plan

1,561

$398.32K

10.3%

ALNY ALNYLAM PHARMACEUTICALS, INC.

27 Jan 2025

CMO & EVP Dev & Med Affairs

Sold on a plan

52,592

$14.99M

81.4%

ALNY ALNYLAM PHARMACEUTICALS, INC.

12 Dec 2024

CMO & EVP Dev & Med Affairs

Sold on a plan

1,752

$439.76K

10.0%

ALNY ALNYLAM PHARMACEUTICALS, INC.

26 Nov 2024

CMO & EVP Dev & Med Affairs

Sold at will

1,682

$422.14K

8.8%

ALNY ALNYLAM PHARMACEUTICALS, INC.

25 Jun 2024

CMO & EVP Dev & Med Affairs

Sold at will

2,103

$485.77K

11.9%

ALNY ALNYLAM PHARMACEUTICALS, INC.

28 Feb 2024

CMO & EVP Dev & Med Affairs

Sold at will

574

$89.14K

6.2%

ALNY ALNYLAM PHARMACEUTICALS, INC.

16 Feb 2024

CMO & EVP Dev & Med Affairs

Sold at will

1,308

$193.67K

15.1%

ALNY ALNYLAM PHARMACEUTICALS, INC.

7 Aug 2023

CMO & EVP Dev & Med Affairs

Sold at will

4,166

$766.08K

48.9%

ALNY ALNYLAM PHARMACEUTICALS, INC.

4 Aug 2023

CMO & EVP Dev & Med Affairs

Sold at will

3,461

$643.22K

28.9%

ALNY ALNYLAM PHARMACEUTICALS, INC.

28 Apr 2023

CMO & EVP Dev & Med Affairs

Sold at will

2,455

$488.60K

36.1%

ALNY ALNYLAM PHARMACEUTICALS, INC.

27 Apr 2023

CMO & EVP Dev & Med Affairs

Sold at will

1,839

$357.85K

21.3%

ALNY ALNYLAM PHARMACEUTICALS, INC.

3 Mar 2023

CMO & EVP Dev & Med Affairs

Sold, plan not stated

18,072

$3.61M

80.6%

29 decisions on file.